News

The S&P 500 Index ($SPX ) (SPY ) is down -0.54% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.96%. E-mini S&P futures (ESU26 ) are down -0.50%, and September E-mini Nasdaq futures (NQU26...

Oscar Health's membership jumps 46% to 2.96 million, but seasonal enrollment and medical utilization keep profitability in focus.

The AI rally put Burry’s bearish stance under pressure as Palantir, CoreWeave, Oracle, Micron, Tesla, Nebius and Nvidia all climbed during August.

Sycamore Capital Management, a franchise of Victory Capital Management, released its Q2 2026 investor letter for “Sycamore Mid Cap Value Equity Strategy”. A copy of the letter can be downloaded here. Sycamore Capital’s Mid Cap Value investment team focuses on a bottom-up approach to identify undervalued businesses with growth potential. In Q2 2026, the strategy […]

UNH's improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.

S&P 500 health insurer Centene blew away Q2 earnings forecasts amid lower-than-expected Affordable Care Act Marketplace benefit costs. CNC stock initially moved higher, but shares reversed sharply lower as the company discussed its outlook, including slightly higher Medicaid attrition and a more costly covered population in the second half of 2026. Centene posted Q2 earnings of $2.51 a share, crushing forecasts of $1.09 by $1.42 a share.

HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.

Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.

Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.

CNC reports Q2 results July 28 as investors weigh improving profitability against membership declines and revenue pressure ahead of earnings.

The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.

UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.

Alignment Healthcare's improved profits, raised 2026 outlook and stronger cash flow support the bull case, but its big rally and richer valuation raise the buy bar.

Baird said the outcomes from the final 2025 healthcare exchange risk adjustment transfers support Centene’s prior Q4 commentary and align directionally with Oscar’s comments at a June investor conference.

Molina (MOH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Molina Healthcare (MOH) is back in focus after its Illinois subsidiary secured a HealthChoice Illinois Medicaid Managed Care contract, along with improving Q1 2026 margins and a recent upgrade from Bank of America that lifted investor interest. See our latest analysis for Molina Healthcare. The contract win, improving Q1 2026 margins and Bank of America upgrade have come alongside a 36.7% 90 day share price return, although the 1 year total shareholder return is down 32.8%. This suggests that...

Molina Healthcare secures an Illinois Medicaid managed care contract starting in 2027, reinforcing its position in a key market and supporting long-term growth.

We just covered Forget AI: Legendary Value Investor Seth Klarman Is Buying These 10 Value Stocks in 2026. Molina Healthcare (NYSE:MOH) ranks #8 (see Seth Klarman Is Buying These 5 Value Stocks in 2026). Baupost’s Stake: $84,460,000 Molina Healthcare (NYSE:MOH) is a managed care company focused on government-sponsored health programs — Medicaid, Medicare, and the […]

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MOH's premium valuation reflects confidence in growth, acquisitions and cash strength, even as elevated medical costs pressure margins.

Pfizer (NYSE:PFE) at $25.75, Molina Healthcare (NYSE:MOH) at $186.80, and Halliburton (NYSE:HAL) at $41.29 trade at defensive, cash-generative valuations. Michael Burry purchased these shares for their real earnings and margin stability, and with inflation still pressuring margins across the market, names that generate cash, hold pricing power, and trade at sober multiples carry a structural ... Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year.

ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.

UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.

BofA Securities upgrades Elevance Health and gives a rare double upgrade to Centene and Molina Healthcare.

HUM posts Q1 earnings beat as premiums surge and membership grows, but rising costs and benefit ratio pressure weigh on profit.

Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls

CNC tops Q1 estimates on strong premiums, lifts 2026 outlook with higher revenue and EPS guidance despite membership decline and rising costs.

Is MOH a good stock to buy? We came across a bullish thesis on Molina Healthcare, Inc. on Dasam’s Substack. In this article, we will summarize the bulls’ thesis on MOH. Molina Healthcare, Inc.’s share was trading at $150.12 as of April 20th. MOH’s trailing and forward P/E were 16.83 and 29.76 respectively according to Yahoo Finance. Molina Healthcare, […]

Molina Healthcare, Inc. recently reported first‑quarter 2026 results showing revenue of US$10.80 billion, GAAP net income of US$14 million, and GAAP earnings of US$0.27 per diluted share, alongside much higher adjusted earnings and modest declines in revenue and membership. The company also reaffirmed its full‑year 2026 outlook for about US$42.00 billion in premium revenue and at least US$5.00 in adjusted earnings per diluted share, while booking a US$93 million impairment tied to its...